SG Americas Securities
NVAX icon

SG Americas Securities’s Novavax NVAX Stock Holding History

SG Americas Securities’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-143,100
Closed -$64K – 3170
2024
Q1 		$64K Buy
+143,100
New +$664K ﹤0.01% 2689
2023
Q1 		– Sell
-16,500
Closed -$2.94M – 3461
2022
Q4 		$2.94M Hold
16,500
– – 0.04% 418
2022
Q3 		$2.8M Hold
16,500
– – 0.03% 440
2022
Q2 		$2.3M Hold
16,500
– – 0.02% 663
2022
Q1 		$1.96M Sell
16,500
-100,000
-86% -$8.92M 0.01% 927
2021
Q4 		$4.77M Buy
116,500
+104,500
+871% +$18M 0.03% 522
2021
Q3 		$587K Hold
12,000
– – ﹤0.01% 2354
2021
Q2 		$672K Buy
+12,000
New +$2.2M ﹤0.01% 1794

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $605M AUM 43.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

SG Americas Securities's NVAX Position: Q2 2026 in Review

SG Americas Securities reduced its Novavax (NVAX) stake by 53% in Q2 2026, selling an estimated $665K and leaving 66,837 shares worth $630K. The position accounts for ﹤0.01% of the portfolio, ranked #2190.

SG Americas Securities first reported a position in NVAX in Q2 2013 and has held it in 50 quarters since. The position peaked at $14.6M in Q3 2024. 268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • SG Americas Securities held 66,837 shares of Novavax worth $630K as of Q2 2026.
  • SG Americas Securities sold 74,248 Novavax shares in Q2 2026, an estimated $665K.
  • Novavax made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2190 holding.
  • SG Americas Securities first reported a position in Novavax in Q2 2013 and has held it in 50 quarters since.
  • SG Americas Securities's Novavax position peaked at $14.6M in Q3 2024.
  • 268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.